MERIDIAN BIOSCIENCE INC (VIVO)

US5895841014 - Common Stock

33.97  0 (0%)

After market: 33.99 +0.02 (+0.06%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023
Revenue
YoY % growth
253.7M
26.22%
317.896M
25.30%
333.018M
4.76%
294.11M
-11.68%
EBITDA
YoY % growth
81.56M
66.93%
117.111M
43.59%
92.111M
-21.35%
N/A
EBIT
YoY % growth
68M
74.81%
101.825M
49.74%
75.6M
-25.75%
46.971M
-37.87%
Operating Margin
26.80%32.03%22.70%15.97%
EPS
YoY % growth
0.98
44.12%
1.68
71.43%
1.38
-17.86%
0.84
-39.02%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 23 Q2 / 23 Q3 / 23 Q4 / 23
EPS
Q2Q % growth
0.21
-40.26%
Revenue
Q2Q % growth
73.757M
-16.51%
EBITDA
Q2Q % growth
N/AN/AN/AN/A
EBIT
Q2Q % growth
8.69M
-57.74%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
0.21
-12.50%
0.150.0637.25%
Q3 2022
Q2Q % growth
0.16
-27.27%
0.160.00-1.96%
Q2 2022
Q2Q % growth
0.66
15.79%
0.480.1836.22%
Q1 2022
Q2Q % growth
0.35
-46.15%
0.260.0937.25%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
65.675M
-13.82%
68.782M-3.107M-4.52%
Q3 2022
Q2Q % growth
67.771M
6.71%
68.152M-381K-0.56%
Q2 2022
Q2Q % growth
111.231M
30.45%
101.53M9.701M9.55%
Q1 2022
Q2Q % growth
88.341M
-4.93%
71.699M16.642M23.21%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -4.62%
RevenueN/A N/A 0% -5.21%